You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012015

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 012015 describes COGENTIN, which is a drug marketed by Oak Pharms Akorn and Merck and is included in two NDAs. It is available from one supplier. Additional details are available on the COGENTIN profile page.

The generic ingredient in COGENTIN is benztropine mesylate. There are seven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.
Summary for 012015
Applicant:Oak Pharms Akorn
Ingredient:benztropine mesylate
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 012015
Suppliers and Packaging for NDA: 012015
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
COGENTIN benztropine mesylate INJECTABLE;INJECTION 012015 NDA AUTHORIZED GENERIC Akorn, Inc. 17478-012 17478-012-02 5 AMPULE in 1 CARTON (17478-012-02) > 2 mL in 1 AMPULE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.